Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
The Metals Company has appointed Liam Mallon, ex-President of ExxonMobil Upstream, to its Board of Directors. Mallon's extensive experience in offshore energy projects and capital deployment will support TMC as it advances toward launching the world's first commercial-scale deep seabed mineral operations under U.S. regulatory frameworks. His leader…
Beta Bionics, Inc., a medical device company specializing in advanced diabetes management technology, announced it will release its third quarter 2026 financial results on October 27, 2026, followed by a management conference call and webcast to discuss performance.
Corbus Pharmaceuticals has dosed the first patient in its TEMPO-1 registrational study evaluating CRB-701, a novel Nectin-4 targeted antibody drug conjugate, for treatment of second-line and beyond oropharyngeal squamous cell carcinoma (OPSCC). The Phase 3 randomized controlled trial aims to confirm the drug's efficacy and safety compared to curren…
Sutro Biopharma announced the appointment of Lucas Donigian as Senior Vice President of Business Development, bringing over 20 years of biotech industry experience and a strong track record in oncology collaborations. His expertise is expected to accelerate Sutro's strategic partnerships and support clinical advancement of its antibody-drug conjuga…
Tectonic Therapeutic announced favorable safety, tolerability, and pharmacokinetic results from its Phase 1a clinical trial of TX2100, a novel APJ receptor antagonist antibody for treating Hereditary Hemorrhagic Telangiectasia (HHT). The FDA granted Fast Track designation for TX2100 and cleared the IND application for a Phase 1b trial in HHT patien…
Brunswick Corporation has announced the appointment of Will Sangster as EVP and President of Navico Group, Karly Yuds as SVP and President of Business Acceleration, and Marco Bracalente as Chief Technology Officer. These senior leadership changes follow the recent CEO and Board Chair transitions effective January 1, 2027. The appointments reflect B…
Precision Optics Corporation, a NASDAQ-listed company specializing in advanced optical instruments for medical and defense/aerospace sectors, will host a webcast presentation and one-on-one investor meetings at the Lytham Partners Fall 2026 Investor Conference. The company highlighted its vertically integrated capabilities and broad applications ac…
Veracyte announced that a retrospective analysis of the phase III NRG/RTOG 0815 trial demonstrates their Decipher Prostate Genomic Classifier can predict which intermediate-risk prostate cancer patients benefit from adding short-term androgen deprivation therapy (ADT) to radiation. Patients with higher Decipher scores saw a significant reduction in…
ZenaTech, Inc. reported a remarkable 316% year-over-year revenue increase in Q2 2026 and a 425% increase in the first half of 2026, primarily fueled by its Drone as a Service (DaaS) segment. The company expanded its geographic footprint through multiple acquisitions and newly opened offices internationally. Investments in AI-powered drone technolog…
Byrna Technologies Inc., a Nasdaq-listed personal defense company, has partnered with iHeartMedia's popular The Bobby Bones Show to launch a national media campaign. The campaign includes radio endorsements, podcasts, and digital placements aimed at expanding brand awareness and educating consumers on Byrna’s less-lethal personal safety devices. Th…
Asure Software has launched its AsureCentral platform to its reseller network, extending access from 30,000 direct employer clients to over 85,000 additional employer clients served by resellers. This integration enables resellers to manage payroll, HR, recruiting, time and attendance, and benefits solutions in a single platform, improving user exp…
eGain Corporation released two whitepapers highlighting that inefficient organization of corporate data leads to runaway AI usage costs and trust issues in AI self-service. Their solution involves consolidating company knowledge into a single trusted source and routing routine tasks to traditional software, reducing costs and improving reliability.…
AXIL Brands, Inc., a consumer products company specializing in hearing protection and enhancement devices as well as hair and skin care products, will announce its fiscal first-quarter 2027 financial results on October 6, 2026, after market close. The company will host a conference call to discuss the results and provide a corporate update.
Nayax Ltd and Getnet announced a global strategic partnership to accelerate integrated payments and commerce solutions for unattended business sectors such as vending machines and EV chargers across Latin America and Iberia. The collaboration enables operators to benefit from Nayax's payment technology combined with Getnet's local acquiring network…
3 E Network Technology Group Limited has commenced a global vendor evaluation and Request for Proposal process for procuring advanced hardware, including high-density server clusters, liquid cooling infrastructure, networking equipment, and storage systems, for its multi-megawatt AI compute center in Mikkeli, Finland. The initiative aims to deploy …
Mobilicom Limited, a Nasdaq-listed provider of cybersecure hardware and software solutions for drones and robotics, announced it will showcase its resilient communication technologies at the ADS ISR Drone Showcase in Virginia. This event attracts U.S. defense leaders and unmanned system operators, positioning Mobilicom to strengthen partnerships an…
21X Group has filed for U.S. regulatory permissions to form 21X LLC as a broker-dealer that would operate an alternative trading system (ATS) for trading tokenized securities. The firm has appointed capital markets veteran Ray Tierney to lead U.S. operations as CEO. The move represents 21X Group's first expansion beyond Europe, where its affiliate …
SoundThinking, a Nasdaq-listed public safety technology company, has entered into a definitive merger agreement with Transom Capital Group. Shareholders will receive $8.00 per share in cash plus a non-transferable contingent value right (CVR) for up to $3.00 per share based on revenue milestones of its ShotSpotter and SafePointe products. The upfro…
Glass House Brands Inc., a leading U.S. cannabis company listed on NYSE and CBOE, announces the planned retirement of CFO Mark Vendetti, effective March 31, 2027. The company is conducting a search for a successor and highlights Vendetti's significant contributions over the past five years, supporting its growth in the cannabis sector.
PMGC Holdings Inc.'s subsidiary, NorthStrive Biosciences, has partnered with Charles River Laboratories to perform analytical testing on its engineered probiotic programs EL-22 and EL-32. This collaboration aims to strengthen product characterization and manufacturing consistency as these candidates advance toward clinical development, targeting mu…
Cullinan Therapeutics presents a tactical long after a market-led pullback. CLN-978, a T-cell engaging program aimed at autoimmune targets, retains clinical upside and a tolerability profile that could re-rate the stock if upcoming readouts or partnering interest materialize. This trade outlines entry, stop, and target prices with catalysts and bal…
Beam Therapeutics (BEAM) has tangible clinical progress in AATD and multiple programs moving into pivotal work. With a market cap near $2.5B, a supportive balance sheet, and visible catalysts, we prefer a mid-term long swing to capture follow-through from clinical data and investor rotation into gene editing—while protecting capital with a defined …
Cartesian Therapeutics announced encouraging additional retreatment data for Descartes-08, its investigational CAR-T cell therapy targeting myasthenia gravis (MG). Data from five retreated patients showed sustained and improved symptom relief up to 12 months after retreatment, with a mean 6.6-point reduction in MG-ADL scores. The therapy was well t…
Cellectar Biosciences presented data from a subset analysis of its Phase 2 CLOVER WaM trial showing high response rates in Waldenström Macroglobulinemia patients refractory or resistant to BTK inhibitor therapy using iopofosine I 131. The drug demonstrated a major response rate of 79.2%, overall response rate of 87.5%, and duration of response exce…
Optimi Health Corp., a publicly traded commercial-stage psychedelic drug manufacturer, appointed Melanie Pump, a seasoned financial executive with 25+ years of experience in technology and emerging companies, to its Board of Directors. The company aims to leverage her expertise as it advances its position in the regulated psychedelic pharmaceutical…
